screening

Open Access
Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting
MAARET ESKELINEN, TUOMAS SELANDER, DENISE PEIXOTO GUIMARÃES, KAI KAARNIRANTA, KARI SYRJÄNEN and MATTI ESKELINEN

Anticancer Research June 2025, 45 (6) 2477-2491; DOI: https://doi.org/10.21873/anticanres.17619
Open Access
Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting
MAARET ESKELINEN, TUOMAS SELANDER, DENISE PEIXOTO GUIMARÃES, KAI KAARNIRANTA, KARI SYRJÄNEN and MATTI ESKELINEN

Anticancer Research January 2025, 45 (1) 267-275; DOI: https://doi.org/10.21873/anticanres.17414
Open Access
Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB)
KARI SYRJÄNEN, MAARET ESKELINEN, JANNICA MEKLIN, PANU HENDOLIN, MATTI ESKELINEN and OSMO SUOVANIEMI

Anticancer Research April 2024, 44 (4) 1513-1523; DOI: https://doi.org/10.21873/anticanres.16948
Open Access
Fecal Immunochemical Test (FIT) in Triage of Bleed-positive (Crab+) and Bleed-negative Colorectal Adenoma (Crab−) Patients in Colorectal Neoplasia Screening
MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARÃES, TUOMAS SELANDER, KARI SYRJÄNEN and MATTI ESKELINEN

Anticancer Research August 2023, 43 (8) 3517-3528; DOI: https://doi.org/10.21873/anticanres.16529
Open Access
Diagnostic Accuracy of Fecal Immunochemical Test (FIT) in Bleed-positive and Bleed-negative Colorectal Cancer (CRC) Among a Cohort of 5,090 Subjects who Participated in the Colorectal Neoplasia (CRN) Screening in Brazil
MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARAES, TUOMAS SELANDER, KARI SYRJÄNEN and MATTI ESKELINEN

Anticancer Research April 2023, 43 (4) 1569-1580; DOI: https://doi.org/10.21873/anticanres.16307
You have access
Screening for Ovarian Cancer in the General Population: State of Art and Perspectives of Clinical Research
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research September 2022, 42 (9) 4207-4216; DOI: https://doi.org/10.21873/anticanres.15921
You have access
p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening
MARIA MAGKANA, PANAGIOTA MENTZELOPOULOU, EKATERINI MAGKANA, ANDREAS PAMPANOS, NIKOLAOS VRACHNIS, ELENI KALAFATI, GEORGIOS DASKALAKIS, EKATERINI DOMALI, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, NICHOLAS P. ANAGNOU and KALLIOPI I. PAPPA

Anticancer Research May 2022, 42 (5) 2599-2606; DOI: https://doi.org/10.21873/anticanres.15738
You have access
Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma
PHILLIPE ABREU, RAPHAELLA FERREIRA, VICTOR MINELI, MAURICIO ALVES RIBEIRO, FABIO GONÇALVES FERREIRA, RODRIGO MARTINEZ DE MELLO VIANNA, FLAVIO DANIEL SAAVEDRA TOMASICH and LUIZ ARNALDO SZUTAN

Anticancer Research December 2020, 40 (12) 6573-6784; DOI: https://doi.org/10.21873/anticanres.14682
You have access
Coprevalence and Incidence of Lung Cancer in Patients Screened for Abdominal Aortic Aneurysm
ANNA HOHNECK, TETYANA SHCHETYNSKA-MARINOVA, GERHARD RUEMENAPF, MARGARITA PANCHEVA, RALF HOFHEINZ, JUDIT BODA-HEGGEMANN, ELENA SPERK, PHILIPP RIFFEL, JULIA MICHELS, MARTIN BORGGREFE, IBRAHIM AKIN and MARTIN SIGL

Anticancer Research July 2020, 40 (7) 4137-4145; DOI: https://doi.org/10.21873/anticanres.14413
You have access
Detection of HPV mRNA in Self-collected Vaginal Samples Among Urban Ethiopian Women
SELAMAWIT MEKURIA, MATS JERKEMAN, OLA FORSLUND, SABA FIKRU and CHRISTER BORGFELDT

Anticancer Research March 2020, 40 (3) 1513-1517; DOI: https://doi.org/10.21873/anticanres.14096

Main menu

User menu

Search

screening

Pages